National Buildings Construction Corporation (NBCC) Limited has bagged a Rs. 400 crore contract to develop National Sports University at Imphal, Manipur. Shares of NBCC jumped over 5 per cent intraday in BSE.

The stock of Manappuram Finance Limited has formed a Three Inside Down candlestick pattern on daily time frame.

Ashok Leyland, which offers a range of trucks and heavy vehicles, also posted poor numbers for the month of September. The total number of vehicles sold in September 2019 was 8780, showing 55 per cent YoY decline.

Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) to market Extended Phenytoin Sodium Capsules USP, 100 mg, a generic equivalent of Dilantin 100 mg, of Parke-Davis, division of Pfizer Inc.

Moil Limited informed the exchanges on Tuesday that it has signed Memorandum of Understanding (MoU) with Gujarat Mineral Development Corporation Ltd. (GMDC), an undertaking of Government of Gujarat, in January 2019, to take up project of joint exploration of manganese bearing areas, exploring its feasibility and to conduct mining operations as well as to set up value addition plant in joint venture in Gujarat.

Most of us believe that retirement planning is often taken care by the social security accounts such as EPS and NPS. However, have you ever thought whether the retirement corpus estimated by you is a realistic one or not? Let’s find out.

NCC Limited informed the exchanges on Tuesday that it has bagged a new order worth Rs. 848 crore in the month of September 2019. The order pertains to Building Division and is received from a State Government agency and does not include any internal orders.

Following stocks are close to their 52-weeks low as at 12:31 p.m. on October 01, 2019.

The markets on October 01, 2019 opened gap up. BSE Sensex is trading at 38,706.19, up by 38.36 points and the Nifty is trading at 11,482.95, up by 8.50 points.

Cadila Healthcare on Monday has informed the bourses that it has entered into an agreement with Medicure lnc, a cardiovascular pharmaceutical company to sell its right, title and interest in Zypitamagt (Pitavastatin)